Osteoprotegerin is a new marker of cardiovascular diseases

Terapevticheskiĭ arkhiv
A F VerbovoyL A Sharonova

Abstract

Osteoprotegerin (OPG) is a glycoprotein that is a representative of the tumor necrosis factor-α receptor superfamily. Information about the possible role of OPG in the development of cardiovascular diseases has begun to appear in the literature in recent years. This review discusses the role of increasing the level of OPG in the development and progression of atherosclerosis and as a consequence of coronary heart disease and chronic heart failure.

References

Feb 1, 1994·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·C D HuntJ P Idso
Mar 12, 2003·The Journal of Clinical Endocrinology and Metabolism·Michael SchoppetLorenz C Hofbauer
May 15, 2004·Stroke; a Journal of Cerebral Circulation·Jonathan GolledgeMirko Karan
Sep 13, 2005·Renal Failure·A CrisafulliMichele Buemi
Jan 21, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Wiggo J SandbergPål Aukrust
Nov 7, 2007·The New England Journal of Medicine·John KjekshusUNKNOWN CORONA Group
Mar 28, 2009·Circulation Research·Sara PanizoJose M Valdivielso
Aug 13, 2009·The New England Journal of Medicine·Steven R CummingsUNKNOWN FREEDOM Trial
Jan 11, 2011·Circulation. Heart Failure·Thor UelandLars Gullestad
Oct 4, 2012·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Tae-Jin SongJi Hoe Heo
Jun 16, 2014·Medicina clínica·Oscar Aramburu BodasPrado Salamanca Bautista

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Related Papers

Nihon rinsho. Japanese journal of clinical medicine
Naoki TakahashiJunichiro James Kazama
Nihon rinsho. Japanese journal of clinical medicine
Naoki TakahashiHaruyoshi Yoshida
© 2022 Meta ULC. All rights reserved